Serum concentrations of aminoacylase 1 in schizophrenia as a potential biomarker: a case-sibling-control study
Published in Nordic Journal of Psychiatry, 2022
Diğdem Göverti, Rabia Nazik Yüksel, Hasan Kaya, Nihan Büyüklüoğlu, Çiğdem Yücel, Erol Göka
Aminoacylase 1 (ACY1; EC 3.5.1.14) is a homodimeric, cytosolic, zinc-metalloprotein, and endogenous mammalian enzyme that has a role in the catabolism of N-terminally acetylated proteins and amino acids by proteolytic degradation [5]. It hydrolyses N-acetylated derivates of methionine, glutamine, serine, alanine, glycine, leucine, and valine apart from N-acetyl-L-aspartate catalyzed by Aminoacylase 2 (EC 3.5.1.15) [6,7]. ACY1, also identified as a risk locus at schizophrenia and bipolar disorder, is encoded by chromosome 3p.21 and expressed by various tissue, particularly the brain and kidney [8,9]. Moreover, it regulates the function of the sphingosine kinase 1 enzyme defined with mitogenic and cytoprotective effects on cells [10].